Geniposide suppresses NLRP3 inflammasome-mediated pyroptosis via the AMPK signaling pathway to mitigate myocardial ischemia/reperfusion injury

Abstract Background NLRP3 inflammasome activation and pyroptosis play a significant role in myocardial ischemia reperfusion injury (MI/RI). Geniposide was reported to show potential therapeutic use for MI/RI with its anti-inflammatory and anti-oxidative properties. However, research on the specific...

Full description

Bibliographic Details
Main Authors: Haiyan Li, Dong-Hua Yang, Yanmei Zhang, Fuchun Zheng, Fenfei Gao, Jiajia Sun, Ganggang Shi
Format: Article
Language:English
Published: BMC 2022-06-01
Series:Chinese Medicine
Subjects:
Online Access:https://doi.org/10.1186/s13020-022-00616-5
_version_ 1811344925620436992
author Haiyan Li
Dong-Hua Yang
Yanmei Zhang
Fuchun Zheng
Fenfei Gao
Jiajia Sun
Ganggang Shi
author_facet Haiyan Li
Dong-Hua Yang
Yanmei Zhang
Fuchun Zheng
Fenfei Gao
Jiajia Sun
Ganggang Shi
author_sort Haiyan Li
collection DOAJ
description Abstract Background NLRP3 inflammasome activation and pyroptosis play a significant role in myocardial ischemia reperfusion injury (MI/RI). Geniposide was reported to show potential therapeutic use for MI/RI with its anti-inflammatory and anti-oxidative properties. However, research on the specific mechanism of geniposide has not been reported. Methods The MIRI model of animal was created in male C57BL/6J mice and the hypoxia reoxygenation (H/R) model was established for the in vitro experiments. Neonatal rat ventricular myocytes (NRVMs) and H9c2 cells with knockdown of TXNIP or NLRP3 were used. Geniposide was administered to mice before vascular ligation. HE staining, 2,3,5-triphenyltetrazolium chloride (TTC) staining, echocardiography, oxidative stress and myocardial enzyme detection were used to evaluate the cardioprotective effect of geniposide. Meanwhile, pharmacological approaches of agonist and inhibitor were used to observe potential pathway for geniposide cardioprotective in vitro and in vivo. Moreover, ELISA kits were adopted to detect the levels of inflammatory factors, such as IL-1β and IL-18. The gene and protein expression of NLRP3 and pyroptosis-related factors in heart tissue were performed by RT-PCR, western blotting and immunofluorescence in vivo and in vitro, respectively. Results Our results indicate that geniposide can reduce the area of myocardial infarction, improve heart function, and inhibit the inflammatory response in mice after MI/RI. In addition, RT-PCR and western blotting shown geniposide promoting AMPK phosphorylation to activate myocardium energy metabolism and reducing the levels of genes and proteins expression of NLRP3, ASC, N-GSDMD and cleaved caspase-1, IL-1β, IL-18. Meanwhile, geniposide improved NRVMs energy metabolism, which decreased ROS levels and the protein expression of TXNIP and thus suppressed the expression of NLRP3. AMPK antagonist or agonist and siRNA downregulation of TXNIP or NLRP3 were also verify the effect of geniposide against H/R injury. Further research found that geniposide promoted the translocation of TXNIP and reduce the binding of TXNIP and NLRP3. Conclusions In our study, geniposide can significantly inhibit NLRP3 inflammasome activation via the AMPK signaling pathway and inhibit pyroptosis of cardiomyocytes in myocardial tissues.
first_indexed 2024-04-13T19:55:25Z
format Article
id doaj.art-396ca386ec8442cc9fed5d76890e7c60
institution Directory Open Access Journal
issn 1749-8546
language English
last_indexed 2024-04-13T19:55:25Z
publishDate 2022-06-01
publisher BMC
record_format Article
series Chinese Medicine
spelling doaj.art-396ca386ec8442cc9fed5d76890e7c602022-12-22T02:32:22ZengBMCChinese Medicine1749-85462022-06-0117112010.1186/s13020-022-00616-5Geniposide suppresses NLRP3 inflammasome-mediated pyroptosis via the AMPK signaling pathway to mitigate myocardial ischemia/reperfusion injuryHaiyan Li0Dong-Hua Yang1Yanmei Zhang2Fuchun Zheng3Fenfei Gao4Jiajia Sun5Ganggang Shi6Department of Pharmacology, Shantou University Medical CollegeDepartment of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John’s UniversityDepartment of Pharmacology, Shantou University Medical CollegeDepartment of Pharmacology, Shantou University Medical CollegeDepartment of Pharmacology, Shantou University Medical CollegeReproductive Center of the First Affiliated Hospital of Shantou University Medical CollegeDepartment of Pharmacology, Shantou University Medical CollegeAbstract Background NLRP3 inflammasome activation and pyroptosis play a significant role in myocardial ischemia reperfusion injury (MI/RI). Geniposide was reported to show potential therapeutic use for MI/RI with its anti-inflammatory and anti-oxidative properties. However, research on the specific mechanism of geniposide has not been reported. Methods The MIRI model of animal was created in male C57BL/6J mice and the hypoxia reoxygenation (H/R) model was established for the in vitro experiments. Neonatal rat ventricular myocytes (NRVMs) and H9c2 cells with knockdown of TXNIP or NLRP3 were used. Geniposide was administered to mice before vascular ligation. HE staining, 2,3,5-triphenyltetrazolium chloride (TTC) staining, echocardiography, oxidative stress and myocardial enzyme detection were used to evaluate the cardioprotective effect of geniposide. Meanwhile, pharmacological approaches of agonist and inhibitor were used to observe potential pathway for geniposide cardioprotective in vitro and in vivo. Moreover, ELISA kits were adopted to detect the levels of inflammatory factors, such as IL-1β and IL-18. The gene and protein expression of NLRP3 and pyroptosis-related factors in heart tissue were performed by RT-PCR, western blotting and immunofluorescence in vivo and in vitro, respectively. Results Our results indicate that geniposide can reduce the area of myocardial infarction, improve heart function, and inhibit the inflammatory response in mice after MI/RI. In addition, RT-PCR and western blotting shown geniposide promoting AMPK phosphorylation to activate myocardium energy metabolism and reducing the levels of genes and proteins expression of NLRP3, ASC, N-GSDMD and cleaved caspase-1, IL-1β, IL-18. Meanwhile, geniposide improved NRVMs energy metabolism, which decreased ROS levels and the protein expression of TXNIP and thus suppressed the expression of NLRP3. AMPK antagonist or agonist and siRNA downregulation of TXNIP or NLRP3 were also verify the effect of geniposide against H/R injury. Further research found that geniposide promoted the translocation of TXNIP and reduce the binding of TXNIP and NLRP3. Conclusions In our study, geniposide can significantly inhibit NLRP3 inflammasome activation via the AMPK signaling pathway and inhibit pyroptosis of cardiomyocytes in myocardial tissues.https://doi.org/10.1186/s13020-022-00616-5Myocardial ischemia reperfusionGeniposideAMPKNLRP3 inflammasomePyroptosis
spellingShingle Haiyan Li
Dong-Hua Yang
Yanmei Zhang
Fuchun Zheng
Fenfei Gao
Jiajia Sun
Ganggang Shi
Geniposide suppresses NLRP3 inflammasome-mediated pyroptosis via the AMPK signaling pathway to mitigate myocardial ischemia/reperfusion injury
Chinese Medicine
Myocardial ischemia reperfusion
Geniposide
AMPK
NLRP3 inflammasome
Pyroptosis
title Geniposide suppresses NLRP3 inflammasome-mediated pyroptosis via the AMPK signaling pathway to mitigate myocardial ischemia/reperfusion injury
title_full Geniposide suppresses NLRP3 inflammasome-mediated pyroptosis via the AMPK signaling pathway to mitigate myocardial ischemia/reperfusion injury
title_fullStr Geniposide suppresses NLRP3 inflammasome-mediated pyroptosis via the AMPK signaling pathway to mitigate myocardial ischemia/reperfusion injury
title_full_unstemmed Geniposide suppresses NLRP3 inflammasome-mediated pyroptosis via the AMPK signaling pathway to mitigate myocardial ischemia/reperfusion injury
title_short Geniposide suppresses NLRP3 inflammasome-mediated pyroptosis via the AMPK signaling pathway to mitigate myocardial ischemia/reperfusion injury
title_sort geniposide suppresses nlrp3 inflammasome mediated pyroptosis via the ampk signaling pathway to mitigate myocardial ischemia reperfusion injury
topic Myocardial ischemia reperfusion
Geniposide
AMPK
NLRP3 inflammasome
Pyroptosis
url https://doi.org/10.1186/s13020-022-00616-5
work_keys_str_mv AT haiyanli geniposidesuppressesnlrp3inflammasomemediatedpyroptosisviatheampksignalingpathwaytomitigatemyocardialischemiareperfusioninjury
AT donghuayang geniposidesuppressesnlrp3inflammasomemediatedpyroptosisviatheampksignalingpathwaytomitigatemyocardialischemiareperfusioninjury
AT yanmeizhang geniposidesuppressesnlrp3inflammasomemediatedpyroptosisviatheampksignalingpathwaytomitigatemyocardialischemiareperfusioninjury
AT fuchunzheng geniposidesuppressesnlrp3inflammasomemediatedpyroptosisviatheampksignalingpathwaytomitigatemyocardialischemiareperfusioninjury
AT fenfeigao geniposidesuppressesnlrp3inflammasomemediatedpyroptosisviatheampksignalingpathwaytomitigatemyocardialischemiareperfusioninjury
AT jiajiasun geniposidesuppressesnlrp3inflammasomemediatedpyroptosisviatheampksignalingpathwaytomitigatemyocardialischemiareperfusioninjury
AT ganggangshi geniposidesuppressesnlrp3inflammasomemediatedpyroptosisviatheampksignalingpathwaytomitigatemyocardialischemiareperfusioninjury